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Introduction
1Introduction
Fine Needle Aspiration Cytology has been used to diagnose Breast Cancer for 
over 50 years. In recent years, it has gained acceptance as a diagnostic tool in 
assessment and management of mammary lesions. 
With the advent of mammography and Ultrasound, these investigations were 
used to recognize breast lesions. Regardless of the sex of the patient and the method 
used to diagnose the lesion, cytological techniques play an important role in the 
diagnosis of breast lesions.
Fine Needle Aspiration Cytology is successful in identification of benign and 
malignant breast lesions, but its role in proliferative breast lesions is poorly defined. 
To expand the role of FNAC in diagnosing of proliferative breast lesions, the analysis 
of cytomorphological features of proliferative breast lesions in conjunction with 
cytological scoring system proposed by Masood et al and with histopathology was 
done.
Relative Risk of developing Invasive breast cancer from carcinoma in situ, from 
proliferative breast disease with atypia, proliferative breast disease without atypia 
and non proliferative breast disease is of the order of 8 – 10, 4 – 5 , 1.5 – 2 , and 1 
respectively
1
. Hence, it is very important to identify proliferative breast disease.
2This study was undertaken to categorise the breast lesions into four 
categories depending on nuclear dissociation, myoepithelial cells, pleomorphism of 
cells, anisonucleosis, nuclear chromatin and nucleoli. The four categories are  
1. Non-Proliferative Breast Disease,
2. Proliferative Breast Disease without Atypia
3. Proliferative Breast Disease with Atypia 
4. Carcinoma. 
The categorization of proliferative breast lesions by FNA remains a challenge 
to the pathologist and the cytologic criteria need to be further defined and assessed. 
Decreasing the number of diagnostic categories is likely to improve the correlation 
between the cytologic and histologic diagnoses without compromising patient 
management. 
Aims of 
the Study
3Aims of the Study
The study aims to correlate the Cytomorphological Diagnosis and the Modified 
Masood’s scoring system with Histopathological Diagnosis in palpable Breast Lesions.
Age distribution of case under different categories of diagnoses are also 
studied.
Review of 
Literature
4Review of Literature
The use of cytology for diagnosis of breast lesions dates back to the early 
1930s, when Martin and Ellis first reported their experience with FNA at the 
Memorial Hospital for Cancer and Allied Diseases in New York
2
. This was followed in 
the late 1940’s and the early 1950’s by Adair and Godwin. However, not until the 
Europeans reported a large series of a number of FNAC of the breast was Aspiration 
Cytology shown to be a valuable and accurate diagnostic procedure.
The sensitivites of Open Biopsy and FNAC are comparable ( 99% for the 
former and 96.2 % for the latter). The specificity of FNAC is better ( 98.8 % vs 85.5% 
for open biopsy).
3
Aspiration biopsy of breast lesions has become a quasi-routine clinical 
procedure, often replacing per-op tissue biopsy. FNAC is the least expensive method 
and the most rapid and most versatile of all approaches.
FNAC can be used for palpable masses that may be either solid or cystic or 
nonpalpable lesions detected by Mammography, Ultrasound or MRI.
It is the consensus of most observers that in most cases, 2 to 4 passes of 
needle are required to harvest optimal diagnostic material. Most authorities define a 
numerical cut-off for cellularity of atleast 6 epithelial cell groups with 5 to 10 cells per 
group for adequacy
1
.
5Embryology:
The Human Mammary Gland develops during the 5
th
week of Gestation at 
which time, thickenings of the ectoderm appear on the ventral surface of the fetus. 
These mammary ridges, also known as milk lines, extend from the axilla to the groin. 
Except for a small area in the pectoral region, the bulk of these ridges normally 
regress as the fetus continues to develop.
After the 15
th
week of gestation, the developing breast exhibits transient 
sensitivity to testosterone, which acts on the mesenchyme. The mesenchyme 
condenses around an epithelial stalk on the chest wall to form the breast bud, the 
site of the mammary gland devlopment. 
Solid epithelial columns then develop within the mesenchyme, and these give 
rise to the lobes or segments of the mammary gland. Portions of the fetal papillary 
dermis encase the developing epithelial cords and give rise to the vascularised 
connective tissue that sorrounds the mammary ducts and lobules. The collagen-rich 
reticular dermis extends into the breast to form the Suspensory Ligaments of Cooper. 
Portions of the mesenchyme differentiate into fat between the 20
th
and 32
nd
weeks of Gestation. During the last eight weeks of Gestation, the epithelial cords 
canalise and branch forming lobulo alveolar structures as a result of mesenchymal 
paracrine effect. 
6A depression in the epidermis forms at the convergence of the lactiferous 
ducts. The nipple forms by evagination of the mammary pit near the time of birth.
Anatomy and Histology of Breast:
The breast is a glandular tissue, surrounded by fibro-adipose tissue and  
covered by epidermis. Centrally located is the nipple, surrounded by a circular 
pigmented area, the areola. Tubercles of Montgomery, a specialised sebaceous gland 
of the areola, enlarge during pregnancy and lactation. 
The arteries of the mammary gland are branches of the Internal Mammary, 
External Mammary and Intercostal Arteries. The veins are the Axillary, Internal 
Mammary and Intercostal.
The breast is composed of 15 to 25 lobes that converge on the nipple in a 
radial pattern. Each segment consists of a lactiferous duct, lactiferous sinus, 
segmental collecting duct, sub segmental duct, terminal duct and acini. The collecting 
ducts are lined by columnar cells which are multilayered in the larger ducts. 
The terminal portions of the lactiferous sinus and the lactiferous ducts are 
lined by stratified squamous epithelium. The secretory acini consist of a single layer 
of cuboidal epithelial cells with sorrounding elongated myoepithelial cells resting on 
a basement membrane.The acini are set within the loose specialised stroma that 
defines the lobular unit. 
7The sorrounding lobular connective tissue contains increased number of 
capillaries and few lymphocytes, histiocytes, plasma cells and mast cells . The lobular 
connective tissue is sharply separated from the more dense periductal fibrous tissue 
and abundant fat that make up the majority of the breast.
During pregnancy, the breast undergoes lobular and ductal proliferation, with 
evidence of lactation. After menopause, the breast shows increased amount of fat, 
diminished connective tissue, persistance of the mammary ducts and disappearance 
of the lobules.
Cytology of the Normal Breast:
Cells derived from ducts have round to oval nuclei, 8 to 10 P in diameter, with 
a very small nucleolus or no visible nucleolus. The cytoplasm is scanty. The 
myoepithelial cells are recognized as having a small spindly curved dark homogenous 
bipolar nucleus with scant cytoplasm that may either adhere to the epithelial 
fragments or appear singly.
The responsiveness of the breast epithelium to cyclic hormonal influences 
have been shown in Fine Needle Aspiration specimens. Post ovulatory aspirates are 
characterised by an increase in the number of acinar cells with all cells including the 
ductal cells displaying more features of acinar cells. Peripheral orientation of the 
nuclear chromatin with clearing is seen. The cytoplasm is lacy and fragile. The 
8epithelial fragments show a multilayered arrangement with marked superimposition 
of cells.
In pre ovulatory aspirates, the cell borders are more prominent, with the 
cytoplasm appearing more even in consistency and better delineated. The nucleus is 
small and more compact with evenly distributed chromatin. Epithelial fragments are 
arranged in single layered sheets. The stroma is composed of fat and loose or fibrous 
connective tissue.
The cytological reporting categories are :
Malignant
Suspicious
Atypical
Benign specific
Benign – non-specific
Unsatisfactory sample 
A palpable breast lump is a common diagnostic problem. Excisional Biopsy 
was accepted practice in the past, but presently, Radiological Imaging in combination 
with needle biopsy makes it possible to reduce unnecessary surgical excision of 
benign breast lesions to a minimum.
9Carter et al
4
studied the relationship between benign breast disease and 
subsequent breast cancer in 16,692 women. Women were classified into one of the 5 
benign breast disease categories:
x Atypical Hyperplasia
x Proliferative Disease without Atypia
x Non Proliferative Breast Disease
x Fibroadenoma 
x Others
Relative risk estimates of breast cancer for women in the 5 benign breast disease 
categories compared with screened women who did not develop recognizable breast 
disease were computed using the proportional hazards model. Results indicated that 
the risk was associated with the degree of epithelial atypia. 
Women with nonproliferative breast disease, proliferative breast disease without 
atypia and atypical hyperplasia displayed progressively increasing risk of 1.5, 1.9 and 
3 respectively, compared with normal subjects with 95% confidence intervals 
exceeding unity
5
.
Dupont et al attempt to quantitate the relative risk of breast carcinoma with 
the degree of proliferation and atypia of intraductal epithelial proliferation of the 
breast.
10
Table 1 : DuPont and Page : Relative Risk of Carcinoma in various categories
The cytological reporting category does not help us in assessing the relative 
risk of different lesions turning malignant. In the current study, Dupont & Page’s 
categorisation of breast lesions has been used.
The study showed a relative risk for cancer of 1 for Non-proliferative Breast 
Disease and a relative risk of 1.9 for proliferative Breast Disease without Atypia, and 
a risk of 5.3 for Proliferative Breast Disease with Atypia.
Based on this study, Breast Lesions were categorised as follows:
Study Study Design Nonproliferative Proliferative 
without 
atypia
Atypical 
hyperplasia
Nashville
6
Retrospective 
Cohort
1 1.9 5.3
Nurses Health 
Study
7
Case-Control 1 1.6 3.9
Breast Cancer 
detection and 
Demonstration 
Project
8
Case-Control 1 1.3 4.3
Florence, Italy
9
Case-Control 1 1.3 13.0
11
Categorisation of Breast Lesions according to the criteria of 
Dupont, Page and Rogers:
Non Proliferative
Cysts
Papillary apocrine change
Epithelial-related Calcifications
Mild hyperplasia of the usual type
Duct Ectasia
Proliferative lesions without atypia
Moderate or Florid ductal hyperplasia of the usual type (usual ductal 
hyperplasia)
Intraductal papilloma
Sclerosing adenosis
Fibroadenoma
Atypical hyperplasia
Atypical ductal hyperplasia
Atypical lobular hyperplasia
12
Carcinoma
Non-Invasive
Intraductal Carcinoma with Paget’s Disease
Lobular Carcinoma insitu
Invasive
Invasive Ductal Carcinoma with Paget’s Disease
Invasive Ductal Carcinoma with predominant Intraductal Component
Invasive Lobular Carcinoma
Medullary Carcinoma
Mucinous Carcinoma
Invasive Papillary Carcinoma
Tubular Carcinoma
Adenoid Cystic Carcinoma
Secretory Carcinoma
Apocrine Carcinoma
Metaplastic Carcinoma
Inflammatory Carcinoma
13
Clinical and Cytological Findings 
Cyst:
x Age > 30, Multifocal and Bilateral
x Poorly defined lumpiness on palpation with a shotty feeling
x Scanty, watery or fatty smear
x Benign or Uncertain Mammogram
x Low to Moderate cellularity
x Apocrine Cells in Variable Cellularity
x Foam Cells ( Macrophage or Epithelial origin)
x Sheets or Fragments of Non apocrine Ductal Epithelium with bland 
nuclei arranged in honey comb pattern with admixed myoepithelial 
cells
x Dispersed stromal bipolar nuclei
x Fat or Fibrous Stroma in variable quantities
x Haagensen states that the initial insult of fibrocystic diseases is 
periductal mastitis, resulting in periductal scarring
10
.
x Proliferative lesions accompanying Fibrocystic Disease are
o Sclerosing Adenosis
o Collagenous Spherulosis
o Papillomatosis
o Ductal Hyperplasia
14
o Atypical Ductal Hyperplasia
x Differential Diagnosis
o Adenoid Cystic Carcinoma
o Collagenous Spherulosis
o Signet-ring cell Carcinoma
Mastitis
Acute Mastitis or Breast Abscess:
x Cytology shows Neutrophils, Foamy Macrophages, Cell debris in the 
background
x Atypical epithelial cells with features of regeneration and repair 
including nuclear enlargement and prominent nucleoli
x Microorganisms ( Infectious Mastitis )
Granulomatous Mastitis :
Differential Diagnosis of Granulomas in the breast include Infectious 
Granulomas (Tuberculosis, Fungi, Leprosy, Brucella), Sarcoid, Tumour, Fat Necrosis, 
Foreign Body reaction and Idiopathic Granulomatous Mastitis.
x Granulomas show clusters of Epithelioid Histiocytes, with or without 
Multinucleated Giant Cells, Lymphocytes and Plasma Cells.
15
Fat Necrosis :
x History of Trauma with or without bruising of the skin
x Tender on Palpation
x Foamy Macrophages and multinucleated giant cells with foamy 
cytoplasm
x Fragments of Normal Adipose tissue
x Variable number of other inflammatory cells.
x Few epithelial cells
x Free Lipid Droplets
x Granular Background
Papillary Apocrine Change:
x Papillary proliferation of ductal epithelial cells in which all of the cells 
show Apocrine features
Epithelial Hyperplasia :
Intraductal Epithelial proliferation includes a spectrum ranging from 
intraductal hyperplasia without atypia to atypical ductal hyperplasia to ductal 
carcinoma in situ.
x Clinical picture is usually benign but may be suspicious 
16
x Low or Moderate Cellularity with small epithelial groups suggest 
Fibroadenosis, Sclerosing Adenosis or Other Sclerosing lesions
x High Cellularity with large flat or folded sheets of cohesive regular 
monolayered cells suggest Epitheliosis when there is regular spacing of 
nuclei within the sheets
x Adenosis lesions frequently show a microacinar appearance in smears
x Nuclei may be enlarged and nucleoli are visible but inconspicuous
x The Groups contain smaller, darker, ovoid nuclei of myoepithelial cells
x Variable number of stromal cell bipolar nuclei are seen between the 
groups. If stromal cells are frequent, a sclerosing lesion may be
suspected
x If separate epithelial cells are present, they should have a fine 
chromatin pattern and small nucleoli.
x The Nuclear Membrane appears smooth
x Macrophages and apocrine cells may be present
x An absence of nuclear atypia, widespread poor cell cohesion or 
necrotic debris.
Mild Hyperplasia:
x Increase in the number of epithelial cells within a duct that is less than 
4 epithelial cells in depth
x Epithelial cells do not cross the lumen
17
Moderate or Florid Hyperplasias:
x Intraductal Epithelial proliferations are more than 4 epithelial cells in 
depth
x They bridge and distend the space 
x Cytologically, the cells are benign and variable in shape, size and 
orientation
x Arranged in a swirling pattern
x 2 distinct cell populations seen
According to Sneige and Staerkel
11
aspirates from Ductal Epithelial Hyperplasia 
show groups of epithelial cells admixed with myoepithelial cells and stromal cells 
arranged in a complex or cribriform fashion. Cell streaming with overriding nuclei or 
tapered intercellular bridges is a feature of ductal hyperplasia.
Atypical Ductal hyperplasia:
x Cell-rich smears, large sheets of cohesive epithelial cells, few single 
cells
x Focal Crowding and overlapping of nuclei, holes suggestive of 
cribriform pattern
x Mild to moderate Nuclear Atypia
x Few Naked Bipolar and Myoepithelial nuclei
18
It is generally agreed that Fine Needle Aspiration Cytology cannot reliably 
distinguish atypical Ductal Hyperplasia from a Non-Comedo type of Ductal Carcinoma 
in situ. Surgical Biopsy confirmation is required whenever atypical ductal hyperplasia 
or ductal carcinoma in situ, non-comedo type is suggested by the cytological findings.
Atypical Lobular Hyperplasia:
x Monomorphic cells, Evenly spaced and dyshesive with round or oval 
eccentric nuclei, pale cytoplasm with intracytoplasmic vacuoles
Intraductal Papillomas:
x Age range of 50 – 60 years
x Clinically presents with nipple discharge and a mass identifiable only 
after careful palpation
x Moderate to high cellularity
x Epithelial cells are often dispersed or in small groups with papillary 
clusters
x Small number of stromal cells
x Apocrine cells may be present
x Small amount of debris and macrophages may be present
x Differential Diagnosis : Fibroadenoma
19
Fibroadenoma:
x Common in age group of 20 – 35 years
x 5 – 30 mm diameter, mobile lump
x Benign Mammographic appearance of a round, well-defined lesion
x Moderate or High Cellularity
x Cohesive Sheets with an antler like appearance
x Many naked bipolar cell nuclei
x Apocrine or Foam cells may also be present
x Fragments of fibromyxoid stroma
Bottles et al
12
, using stepwise logistic regression analysis, demonstrated that 
stromal fragments, antler horn clusters and marked cellularity were the three most 
useful cytological variables to distinguish fibroadenoma from fibrocystic disease.
Dejmek and Lindholm 
13
applied Bottle’s criteria to a series of fibroadenomas 
and noted that stromal fragments were found in only 57% of the cases, antler horn 
clusters in 90 % and honey-comb sheets in 81%.
Stanley et al
14
state that Fine-needle aspiration cytology of fibroadenomas 
with atypia could mimic carcinoma. The atypia was due to multifactorial causes 
including hormonal stimulation, inflammation, metaplastic changes and pre-
neoplastic atypia.
20
Phyllodes tumour
x Cellular Smear
x Biphasic population of Epithelial and Stromal Cells
x Hypercellular stromal fragments consisting of spindle shaped cells 
present singly and enmeshed in metachromatically staining stroma.
x Stromal cell atypia is a feature of Malignant Phyllodes
x Epithelial hyperplasia can be present
x Numerous bipolar naked nuclei
Complex Sclerosing Lesions / Radial Scars:
x Features similar to fibrocystic change
x Epithelial hyperplasia with or without atypia
x Angular groups of epithelial cells with mild nuclear atypia
x Fragments of fibrotic and elastotic stroma
Sclerosing Adenosis / Adenosis Tumour:
x Age range of 20 – 67 years
x Average size of 2.5 cm
21
x Epithelial aggregates may show microacinar pattern
x There may be some loss of cell cohesion and mild nuclear atypia, but 
single bipolar nuclei are usually present
x Stromal fibrosis and changes of proliferative fibrocystic disease
x Differential Diagnosis : Myo-epithelioma, which shows cohesive 
irregular clusters of spindle shaped cells.
Orell
15
reported a significant false positve rate of 4.3 % in radial scar / complex 
sclerosing lesions collected from Breast Carcinoma screening.
Adenoma:
Adenoma of Nipple
x Cellular smear consisting of clusters of uniform ductal epithelial cells 
and dissociative bipolar naked nuclei
16
,
17
.
Papillary adenoma, Eccrine Spiradenoma and Ductal Carcinoma show features 
similar to proliferative Fibrocystic Change.
Lactating Adenoma:
x Cell-rich smear containing an uniform population of epithelial cells, 
which are dispersed with occasional cell clusters
18
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x Epithelial cells with fragile, frayed, granular to foamy to vacuolated 
cytoplasm
x Mildly enlarged, Well Dispersed, Hyperchromatic nuclei with prominent 
nucleoli
x Greater numbers of stripped epithelial nuclei present
x Dirty background of cytoplasmic fragments and secretory material
x False positive diagnosis of malignancy is possible owing to the pattern 
of dissociated epithelial cells stripped of cytoplasm coupled with larger 
epithelial cells, demonstrating nuclear atypicality and prominent 
irregelar nucleoli.
19
Granular Cell Tumour
x Cellular Aspirate
x Groups of Cells with abundant granular cytoplasm and indistinct cell 
borders
x The nuclei are oval to round and uniform in size with an evenly 
dispersed chromatin pattern
x Grossly and Clinically it mimics Scirrhous Carcinoma.
23
Carcinoma of Breast:
The criteria to distinguish between benign and malignant lesions are:
1. The Cellularity of the Specimen
2. Dispersal of Cells
3. Biphasic Pattern
4. Nuclear Size and Pleomorphism
5. Nucleolar Size
6. Nuclear Membrane Irregularity
7. Nuclear Cytoplasmic Ratio
8. Chromatin texture
9. Nuclear Fragility
10. Mitotic Figures
11. Contents of the Background
Cytological Findings:
x Cell-rich smears
x Single population of Epithelial Cells, No Myoepithelial cells
x Variable loss of Cell Cohesion
x Moderate to severe Nuclear Atypia
x Fibroblasts and fragments of Collagen ( stromal desmoplasia)
x Intracytoplasmic neolumina
x Necrosis Unusual
24
Medullary Carcinoma:
x Cellular smear
x Loose syncytial aggregates and single cells
x Bizarre Tumour cells with prominent nucleoli and occasional stripped 
tumour nuclei.
x Benign lymphoid cells with occasional plasma cells
x Differential Diagnosis : Metastatic Melanoma, Malignant Lymphoma, 
High grade Ductal Carcinoma in situ
Mucinous Carcinoma:
x Abundant pools or strands of mucin
x Aggregates and cell balls of tumour cells
x Occasional Signet-ring malignant cells
x Moderate Nuclear Atypia
x Chicken-wire blood vessels
x Differential Diagnosis : Mucinous Ductal Carcinoma in situ or Atypical 
Ductal Hyperplasia, Mucocele like lesions, Mucinous Fibroadenoma, 
Metastatic Carcinoma
Tubular Carcinoma:
x Low to moderate cellularity
25
x Angulated, pointed, open tubules and glands with comma shaped 
projections
x Little or No cellular Atypia
x Bipolar Naked nuclei occasionally seen
x Fibroblastic cells; fragments of fibromyxoid or elastotic stroma
Papillary Carcinoma:
x Cellular smear
x Three dimensional papillary clusters of uniform atypical cells
x Tall columnar cells
x Naked, enlarged, Atypical epithelial nuclei
x Blood and Hemosiderin laden macrophages
Lobular Carcinoma:
It accounts for 3 – 15 % of all breast carcinomas
20
x Low to moderate cellularity
x Single cells and small clusters, cords and strands of Atypical cells
x Mildly atypical cells with increased nuclear-cytoplasmic ratio 
hypochromatic to Hyperchromatic, oval to irregular nuclei and small 
nucleoli
x Signet-ring cells and intracytoplasmic mucin
x No Bipolar nuclei
26
The most common cause of false negative diagnosis if the breast malignancy is 
accurately sampled is aspiration from lobular carcinoma
21
Apocrine carcinoma cytologically shows both individually scattered and 
syncytial fragments of cells with apocrine features. 
Shinagawa et al
22
state that grape-like clusters of vacuolated cells may be a 
helpful cytological feature for the diagnosis of secretory carcinoma.
Sidawy classified the nonproliferative breast lesions according to 
x Cellularity
o low (< 15 epithelial groups per slide)
o moderate ( 15 – 30 epithelial groups)
o high (> 30 epithelial groups)
x Size of Epithelial Groups
o Small (< 3000 cells)
o Large ( > 3000 cells)
x Intact Lobules
x Cellular Arrangement
o Non – Complex 
(Simple sheets with little folding or branching)
o Complex
(More significant folding, branching, lumen formation or 
three dimensionality)
27
x Number of single epithelial cells
o Grade I о < 10 %
o Grade II – 10 – 20 %
o Grade III – 20 – 30 %
x Size of the nucleus
o Grade I - < 1.5 times the size of RBC
o Grade II - 1.5 to 2.5
o Grade III - 2.5 to 3
Sidawy et al
23
state that using univariate analysis, they were able to identify 6 
cytological features that differed between non-proliferative breast lesions and 
proliferative breast lesions. Proliferative breast lesions show more complexity of 
epithelial groups, slit like spaces, mixture of apocrine metaplasia and nuclear 
pleomorphism, large epithelial groups and cell swirling streaming. The latter feature 
was the only one that showed significance in both air dried and alcohol fixed smears.
The study showed the limited role of FNA in distinguishing nonproliferative 
breast disease from proliferative breast disease and it demonstrated the spectrum of 
cytomorphological features in nonproliferative breast disease
Masood et al
24
,
25
proposed a cytological scoring system in which a  value of 1 
to 4 was given for each of the following features:
Cellular Arrangement
Cellular Pleomorphism
28
Presence of Myoepithelial cells
Anisonucleosis
Nucleoli
Chromatin clumping
A score derived from the sum of these values was used to classify each FNA 
sample, Non Proliferative Breast Disease was diagnosed with a score of 6 to 9,
Proliferative Breast Disease with a score of 10 to 14. The results showed 29 of 34 
(85%) FNA specimens diagnosed as Nonproliferative Breast Disease and 15 of 17 
(88%) FNA specimens diagnosed as Proliferative Breast Disease were found to 
correlate with histological Diagnosis.
Maygarden et al
26
evaluated the cytological features of 99 FNA specimens of 
histologically proven proliferative and nonproliferative fibrocystic change. They 
found no parameter that reached statistical significance in distiguishing between 
these two entities.
According to McDivitt et al
27
benign breast lesions can be categorised by a 
modification of the Black-Chabon Grading system which differentiates hyperplasia 
and atypia. When compared with women who had never had a breast biopsy, 
women with benign breast disease without hyperplasia had an odds ratio of 1.5 
(95% Confidence Limits 1.3 – 1.9), women with hyperplasia without atypia had an 
odds ratio of 1.8 (CL =1.3, 2.4) and women with hyperplasia and atypia had an odds 
29
ratio of 2.6 ( CL = 1.6, 4.1). Fibroadenoma was an independent risk factor (OR = 1.7; 
CL= 1.1,2.5).
Other cytological Breast Cancer scoring systems used are the Robinson 
system, the Moriquand system and Fisher’s system.
Robinson’s system :
Robinson’s system of scoring assesses 6 features, i.e, cell dissociation, nuclear 
margin, cell size, cell uniformity, nucleoli and chromatin. A grade of 1 is given for a 
score of 6 – 11, grade 2 for a score of 12 – 14, grade 3 for a score of 15 – 18.
Moriquand system :
Moriquand scoring assesses 4 features, i.e, cellular characters, nuclear 
features, nucleoli and mitoses. A score of 0 – 3 is given for each feature and a grade 1 
is given for a score d 5 . Scores of 6 – 9 are Graded 2, and Scores of >10 are graded 3.
Fisher’s system :
Fisher’s Modification of Nuclear Grading depends on 4 features : nuclear size, 
nuclear membrane, Chromatin and Positive or Negative nucleoli.
Giard and Hermans
28
found a false positive rate of 0.15% with 
cytomorphological analysis. Dupont and Page
29
et al observed a strong association 
between breast carcinoma risk and Atypical Hyperplasia.
30
Jersey et al state that women with proliferative breast Disease have an 
increased relative risk of subsequent invasive Carcinoma. The risk is stratified 
according to the degree of epithelial proliferation and is elevated in women with a 
Family History of Breast Cancer.
Frost et al
30
evaluated 12 cytological features in 51 benign breast aspirates 
and found that only the presence of a swirling pattern reached statistical significance 
in distinguishing Proliferative Breast Disease and Non-Proliferative Breast Disease.
Materials and 
Methods
31
Materials and Methods
The records of the cytopathology and histopathology laboratory of Kilpauk 
Medical College Chennai were analysed over a period of 2 years ( from June 2006 to 
September 2008). One Hundred FNAC cases were collected and the smears were 
stained with Hematoxylin & Eosin and their histological confirmation were included 
in the study.
Inclusion Criteria :
All palpable breast lumps from Female patients with an adequate smear 
showing 5 to 6 ductal epithelial groups were included in the study.
Exclusion Criteria:
Inflammatory smears and smears with no ductal epithelial cells were 
excluded.
All aspirates were performed as an outpatient procedure without imaging or 
mammographic guidance using a 23 G Needle and a 5 ml syringe. The smears were 
fixed in Absolute alcohol for 20 minutes and then stained by Hematoxylin & Eosin 
method. Aspirates were evaluated according to the Modified Masood Scoring 
System. 
Masood et al proposed a cytological scoring system in which a value of 1 to 4 
was given for each of the following features :
32
1. Cellular Arrangement
2. Presence of Myoepithelial cells
3. Anisonucleosis
4. Cellular Pleomorphism
5. Nucleoli and 
6. Chromatin Clumping
A score derived from the sum of these values was used to classify each FNA 
sample. A score for each category was assigned as follows :
1. Non Proliferative Breast Disease – Score of 6 to 928
2. Proliferative Breast Disease without Atypia – Score of 10 to 14
3. Proliferative Breast Disease with Atypia – Score of 15 to 18
4. Carcinoma – Score of 19 to 24
Masood’s score was modified
31
with a score of 6 to 10 denoting 
Nonproliferative breast disease instead of the original score of 6 to 9.
Cytomorphological Diagnosis and Histopathological Diagnosis were also 
categorised to four groups :
1. Non Proliferative Breast Disease
2. Proliferative Breast Disease without Atypia
3. Proliferative Breast Disease with Atypia
4. Carcinoma 
33
Correlation was calculated using Spearman’s rho and Kendall’s tau coefficients.
SPSS Statistics version 17 was used for the statistical Analysis. The Tables of data 
were constructed in Microsoft Office Excel 2007.
This scoring system yielded very promising results when applied prospectively by 
the authors in a study evaluating 100 radiographically directed FNAs. Their results 
show that 29 of 34 FNA specimens diagnosed as Non Proliferative Breast lesions 
(85%) and 15 of 17 FNA specimens diagnosed as Proliferative Breast lesions were 
found to correlate with the histological Diagnosis.
The scoring system requires good sampling techniques, good cellular yield and 
non-fibrotic stroma for optimum results. 
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Results and 
Observations
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Results and Observations
The cases included in the study were all females with an Age Range of 15 – 65
years. The study included 100 palpable breast lesions. Results were tabulated and 
analysed.
Masood’s score was modified
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with a score of 6 to 10 denoting 
Nonproliferative breast disease instead of the original score of 6 to 9.
The scoring system and cytomorphology correlated with histological diagnosis 
for 77 cases. In 12 cases, the cytomorphological diagnosis correlated well with 
histopathological diagnosis. In 11 cases, the modified Masood scoring system 
correlated well with the histological Diagnosis.
In 7 cases, the Cytomorphological Diagnosis and Histopathological Diagnosos 
correlated well and categorised the patients under Proiferative Breast Disease, while 
the scoring system categorised them under Non-Proliferative Breast disease.
In one case, the cytomorphological Diagnosis categorised the case under 
Poliferative Breast Disease without Atypia, while the Scoring system brought it under 
Proliferative breast Disease with Atypia and the Histopathological Diagnosis was 
Carcinoma.
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In 2 cases the cytomorphological Diagnosis categorised the case under 
Proliferative Breast Disease without Atypia, whereas the scoring system 
overdiagnosed it as Proliferative Breast Disease with Atypia.
In 3 cases, the Cytomorphological diagnosis overdiagnosed and categorised 
the cases under proliferative Breast with Atypia, while the scoring system correlated 
with the histopathological Diagnosis of Proliferative Breast Disease without Atypia.
In 2 cases, the Cytomorphological Diagnosis categorised the cases under 
Proliferative Breast Disease without Atypia, while the Scoring system correlated with 
the Histopathological Diagnosis of Non-Proliferative Breast Disease.
The study shows 2 cytomorphological positives correlated with 
histopathological positivity under the category of nonproliferative breast disease, 
when compared to 4 cases in the scoring system. 61 cases correlated with 
histopathological diagnosis when compared to 56 cases in the scoring system under 
the category of proliferative breast disease without atypia.
Out of the 5 cases of Proliferative Breast Disease with Atypia under Modified 
Masood Scoring system, 3 cases were found to be carcinomas by histology and 2 
cases were found to be fibroadenomas with atypia. The cytomorphological diagnosis 
brought 2 cases under carcinoma, and three cases under proliferative breast disease 
without atypia.
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Under the category of proliferative breast disease with atypia, there were no 
correlating cases. 25 cases correlated with the cytomorphological diagnosis when 
compared to 24 cases in the scoring system under the category of Carcinoma. 
Cytohistological correlation was 88% while correlation of the Modified 
Masood score with Histology was 84%. The correlation was statistically significant 
with a correlation coefficient of 0.832 for Cytology-Histology and 0.821 for Modified 
Masood-Histology. Both the correlation coefficients were significant at the 0.01 level 
(1-tailed).
Sensitivity of the scoring system was found to be 80%, Specificity 100% and 
Positive Predictive Value was 100%, Negative Predictive Value was 92% for a 
diagnosis of Carcinoma.
Sensitivity of FNAC was 83%, Specificity was 100%, Positive Predictive Value 
was 100% and Negative Predictive Value was 93%.
The peak age of incidence of nonproliferative breast disease was found to be 
the third decade. The peak age of incidence of proliferative breast disease was found 
to be the third decade and carcinomas peaked at the 6
th
decade.
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Figure 1 : Age Distribution of Study Population
Figure 2 : Distribution of cases by FNAC Score
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Figure 3 : Distribution of cases by Masood Score
Figure 4 : Distribution of cases by Biopsy Scores
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Figure 5 : Concordance of FNAC and Masood Scores with Biopsy Scores
Figure 6 : Age distribution of cases according to Modified Masood Scoring
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Biopsy
FNA
1 2 3 4 Total
1 2 2 0 0 4
2 2 61 0 3 66
3 0 3 0 2 5
4 0 0 0 25 25
Total 4 66 0 30 100
Table 2 : Biopsy vs FNA Score
Biopsy
Masood
1 2 2 4 Total
1 4 8 0 0 12
2 0 56 0 3 59
3 0 2 0 3 5
4 0 0 0 24 24
Total 4 66 0 30 100
Table 3 : Biopsy vs. Modified Masood Scoring
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Figure 7 : Age Distribution of cases according to Biopsy Score
Figure 8: Age Distribution of cases according to FNAC Score
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Correlations
FNA_Sc Masood B_Score
Kendall's tau_b FNA_Sc Correlation Coefficient 1.000 .776
**
.832
**
Sig. (1-tailed) . .000 .000
N 100 100 100
Masood Correlation Coefficient .776
**
1.000 .821
**
Sig. (1-tailed) .000 . .000
N 100 100 100
B_Score Correlation Coefficient .832
**
.821
**
1.000
Sig. (1-tailed) .000 .000 .
N 100 100 100
Spearman's rho FNA_Sc Correlation Coefficient 1.000 .829
**
.861
**
Sig. (1-tailed) . .000 .000
N 100 100 100
Masood Correlation Coefficient .829
**
1.000 .856
**
Sig. (1-tailed) .000 . .000
N 100 100 100
B_Score Correlation Coefficient .861
**
.856
**
1.000
Sig. (1-tailed) .000 .000 .
N 100 100 100
**. Correlation is significant at the 0.01 level (1-tailed).
Table 4 : Non parametric correlation coefficients
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Figure 9 : Distribution of cases by Histopathology
4
66
30
Distribution of cases under various categories 
by Histopathology
Non-Proliferative Proliferative without atypia Proliferative with atypia Carcinoma
Pic 2 : Biopsy of Phyllodes Tumour
Pic 1 : FNAC of Phyllodes tumour, H&E, 40 X with a score of 9
Pic 3 : FNAC Diagnosis of Phyllodes with a score of 5
Pic 4: Biopsy showing Fibroadenoma
Pic 5 : FNAC Diagnosis of Proliferative Breast Disease with a score of 12
Pic 6 : Biopsy Diagnosis – Infiltrating Ductal Carcinoma
Pic 7 : FNAC Diagnosis - Proliferative Breast Disease with a score of 9
Pic 8 : Biopsy - Tuberculous Mastitis
Pic 9 : FNAC - Sclerosing Adenosis with a score of 13
Pic 10 : Biopsy - Sclerosing Adenosis
Pic 11 : FNAC - Intraductal Carcinoma with a score of 20
Pic 12 : Biopsy - Intraductal Carcinoma
Pic 13 : FNAC Diagnosis of Fibroadenoma with a score of 16
Pic 14 : Biopsy showing Intraductal Carcinoma
Pic 15 : FNAC Diagnosis of Fibroadenoma with a score of 11
Pic 16 : Biopsy Diagnosis of Tubular Adenoma
Pic 17 : FNAC Diagnosis of Fibrocystic Disease with a score of 13
Inset : Cyst Macrophages
Pic 18 : Biopsy showing Infiltrating Papillary Adenocarcinoma
Discussion
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Discussion
The study was initiated to evaluate the applicability of Modified Masood 
Scoring in Cytological Diagnosis of Palpable Breast masses and to compare the 
scoring system with Cytomorphological Diagnosis. The Histopathological Diagnosis 
was considered to be the Gold Standard.
According to Barrows
33
, the FNAC positivity for Breast Cancer varies between 
48 to 88 %. To increase the diagnostic yield of the FNAC, Modified Masood scoring of 
the aspirates were done. The study helps to categorise the lesion so that aspiration 
of minimally suspicious lesions is helpful in initiating excisional biopsy.
Modified Masood’s scoring gives additional information by eliminating benign 
cases and improves the diagnostic yield. Application of scoring in a step-wise manner 
in atypical aspirates can help in selection of cases suitable for biopsy.
The risk of developing subsequent invasive breast cancer is stratified 
according to the degree of epithelial proliferation and atypia. The risk is 1-fold in 
women with Non-proliferative Breast disease, 1.9 fold in women with proliferative 
breast disease and 5.3 in women with carcinoma insitu.
Histological criteria that allow the distinction of these various breast lesions 
are established. Sneige and Staerkel
7
introduced the concept of using architectural 
features cytologically and concluded that the application of both cytological and 
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architectural criteria is more reliable than cytology alone in separating proliferative 
breast lesions.
Dawson et al
34
showed that applying both architectural and cytological criteria 
enhanced diagnostic accuracy. Cytologically, the architectural features of 
proliferative breast lesions may be apparent in the larger breast fragments and 
recapitulate the histologic appearance of these lesions. Slit like lumens, swirling and 
streaming are noted in proliferative breast lesions without atypia. Round spaces may 
be seen in proliferative breast lesions without atypia and with atypia. 
Rigid sublumina and a micropapillary architecture are features of DCIS. 
Thomas et al
35
demonstrated that experience and fine tuning of cytological criteria 
increased the concordance with the histological findings.
All these studies emphasise the importance of adequate sampling to 
minimise, in particular, underdiagnosis.
Criteria for the cytological diagnosis of Fibroadenoma and Carcinoma are well 
established. The sensitivity and specificity of Fine Needle Aspiration Cytology for the 
diagnosis of Fibroadenoma is 86.9 % and 93.8% respectively, while for Carcinomas, 
Sensitivity is 89 – 98 % and Specificity 93 – 98 %.
Proliferative Breast lesions on cytology are categorised into Proliferative 
Breast Disease without atypia, and Proliferative breast disease with Atypia because it 
not possible to delineate all the histological entities on FNAC. However, the 
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diagnostic accuracy in this distinction is still unclear, and the cytological features of 
proliferative breast disease are not well established.
In this study, I have confined myself to palpable breast lesions referred for 
routine FNAC. A high degree of concordance was found between FNA Cytology and 
Histological Diagnosis in cases of proliferative breast disease without atypia and 
carcinoma. In these groups, the scoring system did not contribute any addition 
information.
The peak age of incidence of nonproliferative breast disease was found to be 
the third decade. The peak age of incidence of proliferative breast disease was found 
to be the third decade and carcinomas peaked at the 6
th
decade.
Use of the scoring system can reduce the number of atypical reports and 
hence limit unnecessary procedures performed on patients.
The study has found that in cases showing benign ductal cells and suspected 
to be proliferative breast disease without atypia, the scoring system did not add 
substantially in the evaluation of FNAC. This category is likely to form the majority of 
cases on FNAC and in this group, the laborious application of the scoring system can 
be avoided.
The study found that the diagnosis of atypia or routine cytomorphological 
assessment was influenced more by nuclear pleomorphism than by architectural 
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details. Application of the scoring system evaluated both the nuclear atypia and the 
cytoarchitectural features. 
So ,the scoring system should be applied in a stepwise manner after 
cytomorphological assessment. In cases with cytological diagnosis of proliferative 
breast disease without atypia, and carcinoma, the scoring system offers no 
advantage over cytomorphology.
The scoring system is useful in aspirates with cytological diagnosis of 
proliferative breast disease with atypia.
Summary and 
Conclusions
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Summary and Conclusions
100 cases during a period of two years from September 2006 to September 
2008, of palpable breast lesions were studied. The cytomorphological analysis by 
FNAC and Modified Masood system were taken and correlated with 
histopathological diagnosis. Out of the 100 cases, 4 cases were diagnosed as Non 
proliferative breast Disease and 66 cases were diagnosed as Proliferative breast 
disease without atypia. There were no cases under proliferative breast disease with 
atypia. 30 cases were diagnosed as carcinoma by histopathology. 
With Modified Masood’s scoring, 12 cases were categorized as 
Nonproliferative breast disease, 59 cases were categorized as proliferative breast 
disease without atypia, 5 cases were categorized as proliferative breast disease with 
atypia, and 24 cases were categorized as Carcinoma. 
With FNAC, 4 cases were categorized as nonproliferative breast disease, 25 
cases diagnosed as carcinoma, 66 cases categorized as proliferative breast disease   
without atypia and 5 cases were categorized as proliferative breast disease with 
atypia. 
Sensitivity of the scoring system was found to be 80%, Specificity 100% and 
Positive Predictive Value was 100%, Negative Predictive Value was 92% for a 
diagnosis of Carcinoma.
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Sensitivity of FNAC was 83%, Specificity was 100%, Positive Predictive Value 
was 100% and Negative Predictive Value was 93%.
Both FNAC and Modified Masood’s scoring were found to correlate highly 
with each other and with Histopathology.
In conclusion, Modified Masood’s scoring system can be done to categorize 
the breast lesions into the four categories which correlate highly with FNAC and 
histopathology.
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